PRESS RELEASE published on 02/12/2025 at 11:30, 1 year 6 months ago Inside Information / Other news releases Sensorion announces participation in ARO 48th Annual Midwinter Meeting with focus on gene therapy for deafness. Details of presentations by Sensorion executives included Gene Therapy Sensorion ARO Meeting Deafness Sensorion Executives
BRIEF published on 12/27/2024 at 07:35, 1 year 7 months ago Sensorion Completes Enrollment for Audiogene Phase 1/2 Trial Gene Therapy Sensorion Hearing Loss SENS-501 Audiogene Trial
PRESS RELEASE published on 12/27/2024 at 07:30, 1 year 7 months ago Inside Information / Other news releases Sensorion completes enrollment of the first cohort in the Audiogene Phase 1/2 gene therapy clinical trial, targeting infants with hearing loss disorders Gene Therapy Clinical Trial Sensorion Hearing Loss Disorders Audiogene
BRIEF published on 12/18/2024 at 07:35, 1 year 8 months ago Sensorion Reports Positive Preliminary Results for SENS-501 Gene Therapy Clinical Trial SENS-501 Congenital Deafness Biotechnological Innovation
PRESS RELEASE published on 12/18/2024 at 07:30, 1 year 8 months ago Inside Information / Other news releases Sensorion reports positive safety data and behavioral changes in toddlers from the Audiogene Phase 1/2 Gene Therapy Clinical Trial. Plans KOL event in 2025 for further discussion Gene Therapy Clinical Trial Sensorion Hearing Loss Audiogene
BRIEF published on 11/06/2024 at 07:35, 1 year 9 months ago Sensorion to Join Key Investor Conferences in November 2024 Biotechnology Investor Conferences Sensorion Hearing Loss Therapies Gene Therapy Development
PRESS RELEASE published on 11/06/2024 at 07:30, 1 year 9 months ago Inside Information / Other news releases Sensorion to participate in upcoming investor conferences in November 2024, including Stifel Healthcare Conference and LifeSci Capital & Sofinnova Partners Summit Biotechnology Investor Conferences Clinical-stage Sensorion Hearing Loss Disorders
BRIEF published on 09/20/2024 at 07:35, 1 year 10 months ago Sensorion Unveils Promising New Clinical Advances Biotechnology Clinical Trials Gene Therapy Hearing Loss Small Molecule
PRESS RELEASE published on 09/20/2024 at 07:30, 1 year 10 months ago Inside Information / Other news releases Sensorion announces positive clinical data on gene therapy and small molecule programs at World Congress of Audiology, Paris. Details by key medical professionals Clinical Data Gene Therapy Sensorion World Congress Of Audiology Small Molecule
BRIEF published on 09/18/2024 at 07:35, 1 year 11 months ago Sensorion Reports First Half 2024 Financial Results and Clinical Advances Clinical Trials Gene Therapy 2024 Financial Results Sensorion Hearing Loss Therapies
Published on 08/19/2026 at 04:00, 2 hours 52 minutes ago Momenta, XHEART, and QNX Build an Autonomous Driving Platform Certified to Global Safety Standards
Published on 08/18/2026 at 23:10, 7 hours 42 minutes ago Secure Blockchain Signs Agreement to Sell Delivery Trust(R) Business
Published on 08/18/2026 at 19:45, 11 hours 7 minutes ago ECC Ventures 5 Corp. Enters Into Business Combination Agreement with Bayrock Resources for Qualifying Transaction
Published on 08/18/2026 at 18:30, 12 hours 22 minutes ago Sterling Metals Announces Approval of Arrangement by QcX Gold Shareholders
Published on 08/18/2026 at 17:40, 13 hours 12 minutes ago Largo Physical Vanadium Announces Postponement of Annual Meeting
Published on 08/19/2026 at 06:30, 22 minutes ago Sensirion Holding AG: Sensirion continues on its growth trajectory and increases revenue forecast for 2026
Published on 08/19/2026 at 06:00, 51 minutes ago Half-year results 2026: Implenia increases profitability, order book and free cash flow
Published on 08/18/2026 at 22:00, 8 hours 52 minutes ago Enlight Research publishes updated coverage on Eleving Group
Published on 08/18/2026 at 21:50, 9 hours 1 minute ago Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
Published on 08/18/2026 at 19:00, 11 hours 52 minutes ago HIAG strengthens sustainable financing with third green bond worth CHF 100 million
Published on 08/18/2026 at 11:15, 19 hours 36 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 11 hours ago Aéroports de Paris S.A - July 2026 traffic figures
Published on 08/17/2026 at 08:33, 1 day 22 hours ago Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026
Published on 08/17/2026 at 07:30, 1 day 23 hours ago Disclosure of transactions in own shares from August 10 to August 14, 2026
